These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17344020)

  • 1. AIDS: the genomic hole.
    Follézou JY
    Biomed Pharmacother; 2007; 61(2-3):189. PubMed ID: 17344020
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS and human genome studies, from a hypothesis to systematic approaches.
    Lu DY; Ding J
    Med Hypotheses; 2007; 69(3):695. PubMed ID: 17329035
    [No Abstract]   [Full Text] [Related]  

  • 3. Learning from the elite.
    Trivedi B
    Nature; 2010 Jul; 466(7304):S4. PubMed ID: 20631703
    [No Abstract]   [Full Text] [Related]  

  • 4. Human genes that limit AIDS.
    O'Brien SJ; Nelson GW
    Nat Genet; 2004 Jun; 36(6):565-74. PubMed ID: 15167933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [More and more of HIV non-B infections in Germany, too].
    Apel B
    Dtsch Med Wochenschr; 1997 Oct; 122(40):A9. PubMed ID: 9378042
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of AIDS and cancer in the third millennium.
    Gallo RC
    Am J Med; 1995 Dec; 99(6A):6S-10S. PubMed ID: 8585540
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV immunology needs a new direction.
    Medzhitov R; Littman D
    Nature; 2008 Oct; 455(7213):591. PubMed ID: 18833256
    [No Abstract]   [Full Text] [Related]  

  • 8. [CCR5--the HIV co-receptor--now in Israel].
    Kantor R; Gershoni JM
    Harefuah; 1999 Nov; 137(9):405-9. PubMed ID: 11419046
    [No Abstract]   [Full Text] [Related]  

  • 9. Is an effective HIV vaccine feasible?
    Cohen J
    Science; 2005 Jul; 309(5731):99. PubMed ID: 15994545
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural selection and resistance to HIV.
    Schliekelman P; Garner C; Slatkin M
    Nature; 2001 May; 411(6837):545-6. PubMed ID: 11385558
    [No Abstract]   [Full Text] [Related]  

  • 11. Mucosal innate immunity as a determinant of HIV susceptibility.
    Iqbal SM; Kaul R
    Am J Reprod Immunol; 2008 Jan; 59(1):44-54. PubMed ID: 18154595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular biology of HIV infection: clues for possible therapy.
    Rabson AB
    Immunol Ser; 1989; 44():231-56. PubMed ID: 2489113
    [No Abstract]   [Full Text] [Related]  

  • 13. Detrimental effects of mannose-binding lectin (MBL2) promoter genotype XA/XA on HIV-1 vertical transmission and AIDS progression.
    Mangano A; Rocco C; Marino SM; Mecikovsky D; Genre F; Aulicino P; Bologna R; Sen L
    J Infect Dis; 2008 Sep; 198(5):694-700. PubMed ID: 18637753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The infection and immunity of HIV: hope and thought].
    Shang H
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):220-2. PubMed ID: 17425861
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS, aneuploidy and oncogenes.
    Gordon M
    Nat Biotechnol; 2004 Sep; 22(9):1077; author reply 1077-8; discussion 1078. PubMed ID: 15340467
    [No Abstract]   [Full Text] [Related]  

  • 16. Detecting AIDS restriction genes: from candidate genes to genome-wide association discovery.
    Hutcheson HB; Lautenberger JA; Nelson GW; Pontius JU; Kessing BD; Winkler CA; Smith MW; Johnson R; Stephens R; Phair J; Goedert JJ; Donfield S; O'Brien SJ
    Vaccine; 2008 Jun; 26(24):2951-65. PubMed ID: 18325640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hunt for AIDS vaccine tackles genomes.
    Check E
    Nature; 2006 Jun; 441(7097):1034-5. PubMed ID: 16810213
    [No Abstract]   [Full Text] [Related]  

  • 18. Receding hopes of AIDS vaccines.
    Newmark P
    Nature; 1988 Jun; 333(6175):699. PubMed ID: 3386710
    [No Abstract]   [Full Text] [Related]  

  • 19. AIDS research. Receptor mutations help slow disease progression.
    Cohen J
    Science; 1996 Sep; 273(5283):1797-8. PubMed ID: 8815542
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.